I use to have severe rheumatoid arthritis and I have spoken
I use to have severe rheumatoid arthritis and I have spoken of this before. I was taking a once a week injection of Enbrel for it. My issue was severe flare ups that would inflame a joint so I could not even use it. It only happened to a wrist or shoulder or knee really. But it was disabling. It was something when it first started. I didn’t know what was happening. It was one joint at a time and I handled it for almost a year not knowing what was really happening. Then when it hit two wrist joints at the same time and I couldn’t tie my shoes. I went to the family doctor who did blood work and sent me to a specialist for rheumatoid arthritis.
The specialist told me that Enbrel was a biologic and has been used 10 years at the time in the USA and had 20 years of use in Europe. The doc said that in Europe that some patients used Enbrel for 3 or 4 years and then stopped taking Enbrel and never had another flare up. That it acted like the cure but don’t expect to get lucky like that. It doesn’t happen very often.
Well my luck was realized and after having a cold I could not get rid of about 5 years or so ago. I had this cold for almost a month. I stopped taking Enbrel after about 3 weeks. Enbrel was an immune depressant and I thought my immune system was not recovering from the cold because of that. I had been on Enbrel for just over 4 years or so. After getting over the cold a week or so later I didn’t start Enbrel again and to this day have not have another flare up the past 5 years or so. I am super thankful for what I believe is a immune system reset I received from taking Enbrel.
When someone tells me that Leronlimab is an immune modulator and does these miracle type responses for people. I don’t have a hard time believing this. I experienced something very similar in Enbrel and it made me a believer in immune responses being controlled or reset.
There may be another day when my immune system goes a little haywire and I won’t want to use Enbrel again with its black box warning of liver damage warnings. I think I will ask my doctor to write a prescription for Leronlimab instead.
Some of the investors here researched and found out just what they might need in Leronlimab. Myself… I just got lucky investing in a HIV drug that was going to be filing a BLA in September of 2019 and I invested in Leronlimab in August of 2019. This is why I am here. But I have learned so much more about this immune modulator and it’s 3 MOA’s that I know I will be at some point in the future be asking my doctor to prescribe Leronlimab to me for if nothing else. Just being an old man and having a lot of inflammation. My knees aren’t the best and I could use it right now. To me Leronlimab being so safe and taking it as a preventative drug just rings true to my ear. Given the first chance to be prescribed Leronlimab. I won’t hesitate. The real benefits will be unreal overall and we will get so much more than what we are bargaining for from being on a regular weekly or even monthly dose. This is my opinion. Some day we may hand out Leronlimab like it is candy over the counter.
We sit back and know we have something special… we know there is lots of possibilities for Leronlimab. If you look at the majority of diseases they are inflammation induced or symptoms and just being able to help with inflammation will get us approved for many indications. I use to look at Ohms list of 65+ indications and say wow. I look at it now and wonder just how many more indications will happen for Leronlimab. An immune modulator that works for cancer and so many other nasty diseases. Is their no end to what Leronlimab can do? Everyone should know we have something very special in our investment. We haven’t touched all that we can help with yet. It may take decades to realize all the indications. It’s going to be a fun ride. I hope you all enjoy it as much as I know I will.
I have had one miracle immune system reset and now Leronlimab is going to be my second miracle. This is my hope. I want our management to become our very own pharmaceutical company. This is so important for us. I don’t hear this from the 13d group. This is a huge mistake on their part. I just know they are here to sell us. The big money is and will always be getting in on the ground floor of a platform drug that we develop by ourselves with our own pharmaceutical company. This is and was our last years mission statement and future direction. How can we be so blind as to not see the future of this drug is in our hands only. We can’t let some unknown group steal it away from us and sell it. This is my passion in seeing this through. We know what we have. We just need to develop it and keep building our one drug platform with many indications. I hope everyone has taken the same look that I have. It’s enlightening for me. I hope you see the same way we need to grow our company. It’s what’s best for us all. Isn’t that what we all want. I think so.
GLTU all…
28
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
A New Chapter for Invictus Pharmacy In a world tangled up in red tape, Invictus Pharmacy somehow managed to cut a clear path by earning the LegitScript Healthcare Merchant Certification. Now, it seems like they've joined the ranks of the big players, including the likes of Amazon Pharmacy. It’s not just a shiny badge on their website, folks. It’s better access to...
Continue Reading
The Sky's Not the Limit—It's Just the Beginning Step aside, conventional paths. There's a flight school owner in Sedona, Arizona, making waves by encouraging girls to swap their land-bound dreams for sky-high aspirations. This International Girls in Aviation Day, Michelle Smith wants young dreamers to know their possibilities span as wide as the open sky. Defying...
Continue Reading
A Month to Celebrate Unseen Heroes Take a pause. We're talking about National Service Dog Month. What in the world could be more endearing than a pack of puppies, those hopeful bundles of joy, destined to grow up and play pivotal roles in people's lives? Canine Companions is rolling out the red carpet for these future heroes, with a nine-day Puppy Cam event from September...
Continue Reading
Quantum Leap: Chattanooga's Bold Move So Chattanooga’s making waves again, folks. EPB just unveiled its new big shot, the IonQ Forte Enterprise quantum computer. That's right, they’ve slapped a commercial quantum computer and a networking hub together, right here in this Tennessee city. Is this a tech haven or what? Not to mention, it’s the first in America. A New...
Continue Reading
Revamping AI in Veterinary Practices Out there in San Diego, Vetology's been rolling up its sleeves and getting down to brass tacks with a complete do-over of their AI classifiers. They’ve rebuilt all 94 of them, every last one, on a brand-new architecture. No small task, this overhaul stretched from June to August and it wasn't just paint and polish but a whole new...
Continue Reading
Young Artists Called to Inspire a Cancer-Free World What's the first image that pops into your head when you think of a world free from cancer? That's the magic question on deck for this year's Youth Art Contest by Debbie's Dream Foundation. Imaginations are set to run wild as the competition opens its gates to artists under 18, calling for visions splashed across...
Continue Reading
What's Really Driving GenAI Use in Online Education? Let's not beat around the bush—most folks think students turn to this newfangled generative AI mainly to smooth over academic hurdles or save time. But guess what? The University of Phoenix has gone and poked some holes in that assumption. Study Highlights Key Insights This solid piece of research from the...
Continue Reading
Navigating the AI Terrain in Arbitration It's 2026 and artificial intelligence isn't just a buzzword anymore; it's reshaping every corner of how disputes get resolved. The American Arbitration Association (AAA) has jumped into the mix, launching an AI Ambassador program to tackle a wave of AI-induced challenges. These aren't just academic exercises—this is a hard-nosed...
Continue Reading
Revolutionizing Viticulture with Data In today's wild world, climate change isn't just shifting weather patterns—it's upending the age-old map of wine-making regions. We've got a new player on the field: the World Winery Map. It's digital, massive, and it’s shaking things up for winemakers and grape enthusiasts alike. This platform covers a staggering 4.3 million...
Continue Reading
Nonprofit Models Shine Amid IRS Scrutiny Out in Oxnard, California, there's a brewing storm in the healthcare sector. No, it's not a billing error or yet another scandal. We're talking about a seismic shift that could poke holes in those tax-engineered Section 105(b) programs, all thanks to some hard-hitting IRS memoranda. The Nonprofit–TPA Model: A Safer Bet? Enter...
Continue Reading
Top 5 Most Recently Viewed Articles
CraftCo Distillery and Social House: A New Beginning In Holland, Michigan, the beloved Coppercraft Distillery Tasting Room has transformed into a fresh and inviting space known as CraftCo Distillery and Social House. This revamped destination aims to provide a unique gathering venue where spirits, stories, and community come together. What to Expect at CraftCo CraftCo...
Continue Reading
G Mining Ventures Reports Strong Q2 2025 Production Growth G Mining Ventures Corp. (TSX: GMIN) has reached an impressive operational milestone at its Tocantinzinho Gold Mine. The processing plant has been running at an average rate of 12,890 tonnes per day (tpd) for over a month. The corporation has also released production numbers for the second quarter of 2025,...
Continue Reading
U.S. Plastics Pact Shows Progress in 2023-2024 Impact Report The U.S. Plastics Pact has published its 2023-2024 Impact Report, emphasizing significant advancements towards fostering a circular economy for plastics. This comprehensive report serves as a call to action for collaboration across various sectors, including industries, government agencies, and consumers. With...
Continue Reading
A Toast to Paris Baguette's Strategic Growth Paris Baguette's journey across the U.S. just hit a new landmark, folks. They've opened their 300th café on American soil, right in the Philadelphia International Airport. I tell you, dropping a café in such a bustling spot is like planting a flag in prime real estate, signaling big ambitions. From Streets to Terminals...
Continue Reading
KT&G Sets New Standards with 'AAA' ESG Rating KT&G has recently made headlines by achieving an impressive 'AAA' ESG rating from MSCI, marking a significant milestone in the company's sustainability journey. This rating is the highest classification possible, which highlights KT&G's unwavering dedication to responsible business practices. For over five years, KT&G has...
Continue Reading